Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
10/02/2026 15:29
Feb 10 (Reuters) - Daxor Corp DXR.O: DAXOR CORP - REAFFIRMS FOCUS ON BLOOD VOLUME ANALYSIS TECHNOLOGY DAXOR CORP: ANNOUNCES TRANSITION TO SECURITIES EXCHANGE ACT OF 1934 REPORTING COMPANY Source text: ID:nGNX1x4Tf8 Further company coverage: DXR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device